[Vasculitis. New nomenclature of the Chapel Hill consensus conference 2012]

K Holl-Ulrich1

  • 1Konsultations- und Referenzzentrum für Vaskulitisdiagnostik, Institut für Pathologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland, konstanze.holl-ulrich@uksh.de.

Der Pathologe
|October 25, 2013
PubMed

Insights

The 2012 Chapel Hill Consensus Conference (CHCC) nomenclature updates vasculitis classification based on etiopathology and vessel characteristics. It distinguishes anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides and replaces eponyms with systematic names for better clarity.

Area of Science:

  • Rheumatology and Pathology
  • Immunology
  • Histopathology

Background:

  • Advances in understanding vasculitis etiopathology and disease courses.
  • The need for updated classification reflecting current scientific knowledge.
  • Limitations of previous nomenclature systems.

Framework:

  • The revised Chapel Hill Consensus Conference (CHCC) 2012 nomenclature.
  • Classification based on etiopathology, vessel size, and inflammation type.
  • Distinction between ANCA-associated vasculitides and immune complex small vessel vasculitis.

Implementation:

  • Replacement of eponyms with systematic names (e.g., granulomatosis with polyangiitis).
  • Inclusion of clinically significant but less recognized vasculitis types.
  • Focus on histopathological relevance and updated diagnostic criteria.

Implications:

  • Improved diagnostic accuracy and classification of vasculitis.
  • Enhanced understanding of disease mechanisms and clinical presentations.
  • Guidance for histopathologists in identifying and classifying vasculitis subtypes.

Related Concept Videos

Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
84
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
894
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
5.0K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
424